ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Roche's Tecentriq cocktail hops into the FDA fast lane for another Merck showdown
May 08, 2018The company said Monday that the triplet won FDA priority review for previously untreated patients with advanced lung cancer, and that means it could go toe-to-toe with Merck & Co. by Sept. 5. -
NICE draft guidance rejects Roche's Tecentriq for bladder cancer
August 03, 2017The National Institute for Health and Care Excellence issued draft guidance Wednesday recommending against NHS reimbursement of Roche's Tecentriq (atezolizumab) for treating locally advanced or metastatic urothelial carcinoma in adults after prior platinu
Pharma Sources Insight January 2025
